Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
10/02/2023 | PaxMedica, Inc. | | Payment of Exercise | Common Stock | 6.5k | $0.29 | $1.9k | | 10/02/2023 |
05/25/2023 | RELMADA THERAPEUTICS, INC. | RLMD | Grant | Stock Option (right to buy) | 93k | $3.37 | $313.3k | | 05/25/2023 |
01/03/2023 | First Wave BioPharma, Inc. | AZRX | Grant | Common Stock | 84.7k | $0.00 | $0 | | 01/03/2023 |
12/16/2022 | RELMADA THERAPEUTICS, INC. | RLMD | Grant | Stock Option (right to buy) | 57k | $3.37 | $192.2k | | 12/16/2022 |
10/01/2022 | PaxMedica, Inc. | | Grant | Common Stock | 51.6k | $0.00 | $0 | | 10/01/2022 |
05/25/2022 | RELMADA THERAPEUTICS, INC. | RLMD | Grant | Stock Option (right to buy) | 91.2k | $19.03 | $1.7M | | 12/17/2021 |
04/01/2022 | RELMADA THERAPEUTICS, INC. | RLMD | Sale | Common Stock | 3.3k | $29.00 | $95.7k | | 04/01/2022 |
04/01/2022 | RELMADA THERAPEUTICS, INC. | RLMD | Exercise | Stock Option (right to buy) | 19.8k | $3.24 | $64.2k | | 04/01/2022 |
02/07/2022 | Eton Pharmaceuticals, Inc. | ETON | Grant | Stock Option (Right to buy) | 50k | $3.78 | $189k | | 02/07/2022 |
01/03/2022 | First Wave BioPharma, Inc. | AZRX | Grant | Stock option (right to buy) | 34.5k | $1.45 | $50k | | 01/03/2022 |
09/22/2021 | RELMADA THERAPEUTICS, INC. | RLMD | Exercise | Common Stock | 10k | $4.60 | $46k | | 09/22/2021 |
09/22/2021 | RELMADA THERAPEUTICS, INC. | RLMD | Sale | Common Stock | 1.9k | $29.00 | $55.1k | | 09/22/2021 |
09/22/2021 | RELMADA THERAPEUTICS, INC. | RLMD | Sale | Common Stock | 3.3k | $29.00 | $95.7k | | 09/22/2021 |
09/22/2021 | RELMADA THERAPEUTICS, INC. | RLMD | Sale | Common Stock | 1.4k | $29.00 | $40.6k | | 09/22/2021 |
09/22/2021 | RELMADA THERAPEUTICS, INC. | RLMD | Exercise | Options to purchase common stock | 1.9k | $3.24 | $6.2k | | 09/22/2021 |
08/17/2021 | RELMADA THERAPEUTICS, INC. | RLMD | Exercise | Options to purchase common stock | 10k | $4.60 | $46k | | 08/17/2021 |
07/15/2021 | RELMADA THERAPEUTICS, INC. | RLMD | Sale | Common Stock | 2.1k | $31.03 | $66.3k | | 07/15/2021 |
07/15/2021 | RELMADA THERAPEUTICS, INC. | RLMD | Sale | Common Stock | 1.2k | $32.49 | $37.8k | | 07/15/2021 |
06/01/2021 | RELMADA THERAPEUTICS, INC. | RLMD | Sale | Common Stock | 2.5k | $33.19 | $82.3k | | 06/01/2021 |
06/01/2021 | RELMADA THERAPEUTICS, INC. | RLMD | Sale | Common Stock | 520 | $34.08 | $17.7k | | 06/01/2021 |
05/03/2021 | RELMADA THERAPEUTICS, INC. | RLMD | Sale | Common Stock | 3k | $38.22 | $114.6k | | 05/03/2021 |
05/03/2021 | Eton Pharmaceuticals, Inc. | ETON | Grant | Stock Option (Right to buy) | 19.7k | $8.61 | $169.2k | | 05/03/2021 |
04/01/2021 | RELMADA THERAPEUTICS, INC. | RLMD | Sale | Common Stock | 1.3k | $35.93 | $47k | | 04/01/2021 |
04/01/2021 | RELMADA THERAPEUTICS, INC. | RLMD | Sale | Common Stock | 1.7k | $35.04 | $59.3k | | 04/01/2021 |
03/01/2021 | RELMADA THERAPEUTICS, INC. | RLMD | Sale | Common Stock | 3k | $33.87 | $101.6k | | 03/01/2021 |
02/01/2021 | RELMADA THERAPEUTICS, INC. | RLMD | Sale | Common Stock | 1.7k | $33.90 | $56.4k | | 02/01/2021 |
02/01/2021 | RELMADA THERAPEUTICS, INC. | RLMD | Sale | Common Stock | 1.3k | $33.30 | $44.5k | | 02/01/2021 |
01/07/2021 | RELMADA THERAPEUTICS, INC. | RLMD | Grant | Options to purchase common stock | 100k | $33.43 | $3.3M | | 01/07/2021 |
01/04/2021 | First Wave BioPharma, Inc. | AZRX | Grant | Options (right to buy) | 41.2k | $0.97 | $40k | | 01/04/2021 |
01/04/2021 | RELMADA THERAPEUTICS, INC. | RLMD | Sale | Common Stock | 3k | $32.11 | $96.3k | | 01/04/2021 |
12/01/2020 | RELMADA THERAPEUTICS, INC. | RLMD | Sale | Common Stock | 3k | $35.74 | $107.2k | | 11/24/2020 |
11/24/2020 | RELMADA THERAPEUTICS, INC. | RLMD | Gift | Common Stock | 21.2k | $0.00 | $0 | | 11/24/2020 |
11/02/2020 | RELMADA THERAPEUTICS, INC. | RLMD | Sale | Common Stock | 3k | $30.29 | $90.9k | | 11/02/2020 |
10/01/2020 | RELMADA THERAPEUTICS, INC. | RLMD | Sale | Common Stock | 3k | $37.99 | $114k | | 10/01/2020 |
09/01/2020 | RELMADA THERAPEUTICS, INC. | RLMD | Sale | Common Stock | 3k | $34.74 | $104.2k | | 09/01/2020 |
|